Atossa Therapeutics
ATOS
#10613
Rank
NZ$35.13 M
Marketcap
NZ$3.52
Share price
-5.48%
Change (1 day)
154.20%
Change (1 year)

EPS for Atossa Therapeutics (ATOS)

EPS in 2026 (TTM): NZ-$6.79

According to Atossa Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$6.74. In 2025 the company made an earnings per share (EPS) of NZ-$6.87 a decrease over its 2024 EPS that were of NZ-$5.17.

EPS history for Atossa Therapeutics from 2010 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$6.79-1.28%
2025NZ-$6.8732.89%
2024NZ-$5.17-15.56%
2023NZ-$6.1314.29%
2022NZ-$5.3616.67%
2021NZ-$4.59-90.86%
2020NZ-$50.28-2.96%
2019NZ-$51.81-63.09%
2018NZ-$140.37-49.63%
2017NZ-$278.71-57.87%
2016NZ-$661.55-74.01%
2015NZ-$2,545-9.18%
2014NZ-$2,802-12.86%
2013NZ-$3,21670.73%
2012NZ-$1,88434.07%
2011NZ-$1,405263.41%
2010NZ-$386.58

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$14.86-320.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$15.60-331.57%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$19.33-386.87%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
NZ-$1.31-80.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
NZ-$0.36-94.70%๐Ÿ‡บ๐Ÿ‡ธ USA